Your browser doesn't support javascript.
loading
Two-field resolution on-call HLA typing for deceased donors using nanopore sequencing.
Devriese, Magali; Da Silva, Sephora; Le Mene, Melchior; Rouquie, Julien; Allain, Vincent; Kolesar, Libor; Rigo, Krisztina; Creary, Lisa E; Lauterbach, Nina; Usureau, Cedric; Dewez, Mathieu; Caillat-Zucman, Sophie; Werner, Gregory; Taupin, Jean-Luc.
Afiliación
  • Devriese M; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
  • Da Silva S; INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Le Mene M; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
  • Rouquie J; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
  • Allain V; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
  • Kolesar L; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
  • Rigo K; Omixon Biocomputing Ltd., Budapest, Hungary.
  • Creary LE; Omixon Biocomputing Ltd., Budapest, Hungary.
  • Lauterbach N; Omixon Biocomputing Ltd., Budapest, Hungary.
  • Usureau C; Omixon Biocomputing Ltd., Budapest, Hungary.
  • Dewez M; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
  • Caillat-Zucman S; INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
  • Werner G; Omixon Biocomputing Ltd., Budapest, Hungary.
  • Taupin JL; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
HLA ; 103(3): e15441, 2024 03.
Article en En | MEDLINE | ID: mdl-38507216
ABSTRACT
The current practice of HLA genotyping in deceased donors poses challenges due to limited resolution within time constraints. Nevertheless, the assessment of compatibility between anti-HLA sensitized recipients and mismatched donors remains a critical medical need, particularly when dealing with allele-specific (second field genotyping level) donor-specific antibodies. In this study, we present a customized protocol based on the NanoTYPE® HLA typing kit, employing the MinION® sequencer, which enables rapid HLA typing of deceased donors within a short timeframe of 3.75 h on average at a three-field resolution with almost no residual ambiguities. Through a prospective real-time analysis of HLA typing in 18 donors, we demonstrated the efficacy and precision of our nanopore-based method in comparison to the conventional approach and without delaying organ allocation. Indeed, this duration was consistent with the deceased donor organ donation procedure leading to organ allocation via the French Biomedicine Agency. The improved resolution achieved with our protocol enhances the security of organ allocation, particularly benefiting highly sensitized recipients who often present intricate HLA antibody profiles. By overcoming technical challenges and providing comprehensive genotyping data, this approach holds the potential to significantly impact deceased donor HLA genotyping, thereby facilitating optimal organ allocation strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Secuenciación de Nanoporos Límite: Humans Idioma: En Revista: HLA Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Secuenciación de Nanoporos Límite: Humans Idioma: En Revista: HLA Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido